The use of bioinformatics and statistical tools to investigate, synthesize, combine, and interpret data from laboratory research, clinical studies, electronic health records, imaging data, and other sources into valuable insights is known as translational informatics. Data-driven approaches to advancing the transfer of a compound, device, or intervention from the laboratory to the clinic are known as translational informatics. TI isn't just for bioinformatics or omic sciences, either. The potential of genomics and translational informatics to improve medication development and clinical applications. In the end, translational informatics is a large data issue. Because of the vast number of samples and the amount of data collected each sample, the data volume is enormous. What used to be a handful of genetic panels done on a small clinical study has exploded into massive databases thanks to the introduction of cost-effective sequencing. This extraordinary magnitude and volume necessitate the development of new tools and methods.
Title : Copper (II) complexes as potential anticancer agents
Salah S Massoud, University of Louisiana, United States
Title : Pharmacogenomics: current status and future directions
Matthias Schwab, University of Tübingen, Germany
Title : Talus bone of the hindfoot: Unique anatomy and an important clinical implication
Abdelmonem Awad Hegazy, Zarqa University, Jordan
Title : The use of anti seizure medication therapeutic blood level determination to personalise the treatment of epileptic seizures especially in patients attending the accident and emergency department
Roy Gary Beran, University of New South Wales, Australia
Title : Effect of Fluvoxamine on Interluekin-6 level of COVID-19 patients, hospitalized in ICU: A randomized clinical trial
Mitra Safa, Shahid Beheshti University of Medical Sciences, Iran (Islamic Republic of)
Title : Precision Treatment of Alzheimer's
Boris Tankhilevich, Magtera, Inc., United States